Wnt inhibitory factor 1 (WIF1) methylation and its association with clinical prognosis in patients with chondrosarcoma
Abstract Chondrosarcoma (CS) is a rare cancer, but it is the second most common primary malignant bone tumor and highly resistant to conventional chemotherapy and radiotherapy. Aberrant DNA methylation in the promoter CpG island of Wnt inhibitory factor 1 (WIF1) has been observed in different cancer...
Guardado en:
Autores principales: | Pei Liu, Jacson K. Shen, Francis J. Hornicek, Fuyun Liu, Zhenfeng Duan |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2017
|
Materias: | |
Acceso en línea: | https://doaj.org/article/6a3b2d7f430d47659d79a8211bb8ab85 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Establishment and Characterization of a Novel Dedifferentiated Chondrosarcoma Cell Line DDCS2
por: Xiaoyang Li, et al.
Publicado: (2021) -
Cellular retinol binding protein-1 inhibits cancer stemness via upregulating WIF1 to suppress Wnt/β-catenin pathway in hepatocellular carcinoma
por: Xiangye Liu, et al.
Publicado: (2021) -
The detection of the methylated Wif-1 gene is more accurate than a fecal occult blood test for colorectal cancer screening.
por: Aurelien Amiot, et al.
Publicado: (2014) -
Curcumin blocks interleukin-1 signaling in chondrosarcoma cells.
por: Thomas Kalinski, et al.
Publicado: (2014) -
Clinicopathological significance of p16, cyclin D1, Rb and MIB-1 levels in skull base chordoma and chondrosarcoma
por: Jun-qi Liu, et al.
Publicado: (2015)